In 23 cases (76%), SPHK1 expression appeared to be upregulated in the tumors when compared to the companion normal tissue with the following immunostaining scores: normal: 0.93 ± 0.173; tumor: 2.06 ± 0.46, P < 0.01 (Figure 3B). This evidence concerns the gene SPHK1 and neoplasm.